Difference between revisions of "Allergy & Intolerance"
Elaine Ayres (talk | contribs) |
Elaine Ayres (talk | contribs) |
||
Line 33: | Line 33: | ||
==Allergy/Intolerance Topic Scope Statement== | ==Allergy/Intolerance Topic Scope Statement== | ||
+ | |||
+ | [http://www.hl7.org/special/Committees/projman/searchableProjectIndex.cfm?action=edit&ProjectNumber=1004|Allergy and Intolerance Clinical Models Scope Statement Project 1004] | ||
*[[Media:HL7PSS_PC_CP_AllergyIntoleranceDAM20120430FINAL.docx|Final Project Scope Statement Project 881 (2012-4-30) ]] | *[[Media:HL7PSS_PC_CP_AllergyIntoleranceDAM20120430FINAL.docx|Final Project Scope Statement Project 881 (2012-4-30) ]] |
Revision as of 15:47, 13 August 2013
return to: Patient Care
Current work: Create an Allergy and Intolerance Domain Analysis Model and Clinical Models (DSTU).
Project 881 (Domain Analysis Model) and Project 1004 (Clinical Models)
This is a work in progress. See HL7 Ballot site for existing specification.
This topic covers all interactions related to clinically recorded adverse reactions, including:
- Recording adverse reactions
- Revising existing adverse reaction records
- Retrieving a patient's adverse reaction records
These transactions are not intended for reporting adverse reactions (as managed by Individual Case Safety Reports). Rather, these transactions are intended to be recorded as part of a patient's electronic health record. They supplement allergy and intolerance records for circumstances where it is not clear whether an allergy or intolerance exists. These interactions are crafted to support a 'request-based' architecture in which messages are sent from a point of service (POS) such as a clinic, pharmacy, etc. to a central drug information system (DIS). These messages are phrased as requests because the DIS reserves the right to refuse all requests. Reasons might include the presence of contraindications such as drug-drug interactions or duplicate therapy, as well as more mundane issues such as lack of permission, lack of recorded patient consent, etc.
Contents
- 1 Allergy/Intolerance Topic DSTU
- 2 Allergy/Intolerance Topic Scope Statement
- 3 Patient Care WGM Agenda
- 4 Meeting Minutes
- 5 Presentations
- 6 2012 Use Cases and Storyboards
- 7 2013 Use Cases and Storyboards
- 8 Domain Analysis Model
- 9 Ballot Reconciliation January 2013
- 10 Updated Allergy and Intolerance Glossary
- 11 Past Use Cases and Storyboards
- 12 Models
- 13 Links to Other Relevant Projects
- 14 Discussion
Allergy/Intolerance Topic DSTU
The current "Allergy/Intolerance" topic DSTU expires in June 2012. The "Allergy/Intolerance" project group after some discussion recommends that application to HL7 publishing committee for a 12-month extension of the current DSTU should be considered as the best option forward. The 12-month extension will allow the group with time to perform proper DAM development and to determine how best the current DSTU may be modified and/or extended to meet updated, new requirements.
The following is DSTU extension guidance provided by HL7 HQ:
DSTU extension guidance is offered at the TSC wiki page under TSC Process Guidance, at: http://hl7t3f.org/wiki/index.php?title=DSTU_Publishing_Guidance, where requesting extensions to DSTU should use criteria determined in the TSC’s conference call 2009-03-09:
“Sufficient justification should be provided to describe effort in progress to move the standard towards a normative ballot, such as evidence of current trial activity, if they have a credible expectation that a normative document will be produced within a requested timeframe, given that trials are currently underway. The request must include the length of time required to extend the DSTU, including conclusion of the pilot and subsequent balloting activity...If you send the completed form to me (LynnL) I can put it on the TSC agenda.”
Allergy/Intolerance Topic Scope Statement
and Intolerance Clinical Models Scope Statement Project 1004
Patient Care WGM Agenda
Meeting Minutes
Allergy/Intolerance Project Conference Calls and Meeting Minutes
Presentations
- Proposal To Address Medications, Allergies Disparities In Final Rule MU Stage 2 (2012-10-03) Powerpoint.
- Allergy/Intolerance Concept Model Slides - Andre Boudreau (2012-02-03) updated 2012-01-03 Powerpoint.
- Allergy/Intolerance Concept Discussion Slides - Andre Boudreau (2011-12-20) updated 2012-01-03 Powerpoint.
- Allergy/Intolerance Topic Slides from Russ Leftwich, MD (2011-12-20) Powerpoint in PDF format.
- Canadian model on Allergy & Intolerance (2011-07-19) Powerpoint in PDF format.
2012 Use Cases and Storyboards
- Reported Food Intolerance (2012-4-17)
- Allergy List (2012-5-8)
- Allergy Not Asked (2012-7-11)
- Immunizations (2012-7-26)
- Allergy to Latex (2012-7-26)
- Medication Reaction (2012-7-11)
- Misattribution of Allergy to Nickel Knee Implant (2012-7-26)
- New Food Allergy (2012-4-17)
- No Known History of Allergy (2012-7-11)
- Unable to Determine Triggering Agent (2012-7-11)
- Patient PHR List (2012-10-9)
- Reported Preference(2012-10-9)
2013 Use Cases and Storyboards
Domain Analysis Model
Ballot reconciliation is complete for this DAM as of May 8, 2013. Final Domain Analysis Model will be published with changes.
Ballot Reconciliation January 2013
Updated Allergy and Intolerance Glossary
Past Use Cases and Storyboards
- Allergy/Intolerance Topic Use Cases and Storyboard Summary (2011-08-30)
- From the old Ballot??
- Revised Draft 2007-May-23
Models
- Patient Care RMIM as of Jan 2007
- Patient Care RMIM as of May 2, 2007
- Updated Model as of May 22, 2007
Links to Other Relevant Projects
Structured Document WG: CDA Implementation Guilde Project on Clinical Oncology Treatment Plan and Summary:
http://wiki.hl7.org/index.php?title=Clinical_Oncology_Treatment_Plan_and_Summary